Literature DB >> 1260336

Complement and meningococcal infection.

B M Greenwood, I I Onyewotu, H C Whittle.   

Abstract

Serum C3 levels were measured in 211 patients with meningococcal disease. Low levels were found in 13 patients with acute meningococcaemia, and complement activation may have contributed to the peripheral circulatory collapse that was responsible for nine deaths. The complement profile of these patients suggested activation of both classical and alternative complement pathways. Patients with meningitis had a higher mean serum C3 level than controls. Serial studies in 13 serum antigen-positive patients with meningitis who subsequently developed arthritis or cutaneous vasculitis showed a transient fall in serum C3 in eight. This fall was probably due to the formation of immune complexes that were responsible for their allergic complications.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1260336      PMCID: PMC1639447          DOI: 10.1136/bmj.1.6013.797

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  11 in total

1.  Complement activation in children with acute malaria.

Authors:  B M Greenwood; M J Brueton
Journal:  Clin Exp Immunol       Date:  1974-10       Impact factor: 4.330

2.  Group-specific polysaccharide antigen and humoral antibody response in disease due to Neisseria meningitidis.

Authors:  T A Hoffman; E A Edwards
Journal:  J Infect Dis       Date:  1972-12       Impact factor: 5.226

3.  The potential pathogenic role of complement in dengue hemorrhagic shock syndrome.

Authors:  V A Bokisch; F H Top; P K Russell; F J Dixon; H J Müller-Eberhard
Journal:  N Engl J Med       Date:  1973-11-08       Impact factor: 91.245

4.  Activation of the properdin pathway of complement in patients with gram-negative of bacteremia.

Authors:  D T Fearon; S Ruddy; P H Schur; W R McCabe
Journal:  N Engl J Med       Date:  1975-05-01       Impact factor: 91.245

5.  Activation of the classic and alternate complement pathways by endotoxin.

Authors:  D P Fine
Journal:  J Immunol       Date:  1974-02       Impact factor: 5.422

6.  Serum complement levels in bacteremia due to gram-negative organisms.

Authors:  W R McCabe
Journal:  N Engl J Med       Date:  1973-01-04       Impact factor: 91.245

7.  The pathogenesis of arthritis associated with viral hepatitis. Complement-component studies.

Authors:  E Alpert; K J Isselbacher; P H Schur
Journal:  N Engl J Med       Date:  1971-07-22       Impact factor: 91.245

8.  Interactions of the classical and alternate complement pathway with endotoxin lipopolysaccharide. Effect on platelets and blood coagulation.

Authors:  M A Kane; J E May; M M Frank
Journal:  J Clin Invest       Date:  1973-02       Impact factor: 14.808

9.  Allergic complications of meningococcal disease. II. Immunological investigations.

Authors:  B M Greenwood; H C Whittle; A D Bryceson
Journal:  Br Med J       Date:  1973-06-30

10.  Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum.

Authors:  V A Bokisch; H J Müller-Eberhard; C G Cochrane
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

View more
  22 in total

1.  Complement activation profiles in disease.

Authors:  D L Brown
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1979

2.  Arthritis after meningococcal meningitis.

Authors:  H E Larson; K G Nicholson; G Loewi; D A Tyrrell; J Posner
Journal:  Br Med J       Date:  1977-03-05

3.  Circulating immune complexes in a patient with meningococcal disease.

Authors:  J A Davis; N Peters; I Mohammed; G A Major; E J Holborow
Journal:  Br Med J       Date:  1976-06-12

Review 4.  Interaction of complement with Neisseria meningitidis and Neisseria gonorrhoeae.

Authors:  P Densen
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

5.  The complications and management of meningococcal meningitis.

Authors:  J M Shneerson; I W Fawcett
Journal:  Intensive Care Med       Date:  1979-03       Impact factor: 17.440

Review 6.  Immune complexes in human diseases: a review.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

7.  Magnitude of bacteremia and complement activation during Neisseria meningitidis infection: study of two co-primary cases with different clinical presentations.

Authors:  A Zwahlen; F A Waldvogel
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

Review 8.  Infectious diseases associated with complement deficiencies.

Authors:  J E Figueroa; P Densen
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

Review 9.  Immune complex associated complications in the subacute phase of meningococcal disease: incidence and literature review.

Authors:  C A Goedvolk; I A von Rosenstiel; A P Bos
Journal:  Arch Dis Child       Date:  2003-10       Impact factor: 3.791

10.  Activation of murine B lymphocytes by Neisseria meningitidis and isolated meningococcal surface antigens.

Authors:  J Melancon; R A Murgita; I W Devoe
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.